跳到正文
cccskills
免费在 GitHub 公开

enda-fludrocortisone-aldosterone-deficiency

Recommends initiating fludrocortisone 50–100 µg daily for mineralocorticoid replacement in adults with confirmed aldosterone deficiency (e.g., low aldosterone, elevated renin) and no salt restriction. Use when aldosterone deficiency is confirmed in a patient with primary adrenal insufficiency (PAI) presenting with salt craving or postural hypotension.

中文简介正在准备中。当前显示原文说明。

实测评分 未实测

查看安装方法

包含的文件(1)

  • SKILL.md2.6 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Initiate Fludrocortisone for Aldosterone Deficiency with Specific Starting Dose

STEP 1 — Gather Information

Confirm primary adrenal insufficiency (PAI) diagnosis; measure morning plasma aldosterone and renin to demonstrate low aldosterone with elevated renin; assess for symptoms of mineralocorticoid deficiency (salt craving, postural hypotension, hyponatremia, hyperkalemia); ensure no concurrent salt restriction; review blood pressure for hypertension.

STEP 2 — Rule In / Rule Out

Is aldosterone deficiency confirmed (low aldosterone with inappropriately normal or high renin)?

  • Yes → Proceed to STEP 3.
  • No → Do not initiate fludrocortisone; reassess etiology.

STEP 3 — Classify or Stratify

Is the patient an adult (≥18 years)?

  • Adult → Use starting dose 50–100 µg daily.
  • Pediatric → Refer to pediatric dosing (e.g., 100 µg/d for children, infant salt supplements).

STEP 4 — Decide

Initiate fludrocortisone at 50–100 µg once daily in the morning; counsel patient not to restrict salt intake; schedule follow‑up in 2–4 weeks to assess symptoms, blood pressure, and electrolytes.

Clinical Guardrails / Mimics / Pitfalls

Avoid in patients with uncontrolled hypertension or edema; monitor for signs of over‑replacement (hypertension, supine edema, hypokalemia); do not combine with licorice, grapefruit juice, or potent CYP3A4 inducers that may alter fludrocortisone metabolism; fludrocortisone is not indicated for secondary adrenal insufficiency; if hypertension develops, reduce dose before adding antihypertensives.

Concrete Clinical Example

A 34‑year‑old woman with newly diagnosed PAI (low cortisol, high ACTH) has serum aldosterone 2 ng/dL (low), renin 45 mIU/L (high), reports salt craving and occasional light‑headedness on standing. She is normotensive. Start fludrocortisone 100 µg daily, advise liberal salt intake, and re‑evaluate in 3 weeks.

Source: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-1710

TODO: consider adding scripts/calc.py for the enda-fludrocortisone-aldosterone-deficiency calculator

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题